The regenerative effects of stem cells derived from dental tissues have been previously investigated. This study assessed the potential of human tooth stem cells from apical papilla (SCAP) on nerve regeneration. The SCAP collected from nine individuals were characterized and polarized by exposure to interferon-γ (IFN-γ). IFN-γ increased kynurenine and interleukin-6 (IL-6) production by SCAP, without affecting the cell viability. IFN-γ-primed SCAP exhibited a decrease of brain-derived neurotrophic factor (BDNF) mRNA levels, followed by an upregulation of glial cell-derived neurotrophic factor mRNA. Ex vivo, the co-culture of SCAP with neurons isolated from the rat dorsal root ganglion induced neurite outgrowth, accompanied by increased BDNF secretion, irrespective of IFN-γ priming. In vivo, the local application of SCAP reduced the mechanical and thermal hypersensitivity in Wistar rats that had been submitted to sciatic chronic constriction injury. The SCAP also reduced the pain scores, according to the evaluation of the Grimace scale, partially restoring the myelin damage and BDNF immunopositivity secondary to nerve lesion. Altogether, our results provide novel evidence about the regenerative effects of human SCAP, indicating their potential to handle nerve injury-related complications.
Get full access to this article
View all access options for this article.
References
1.
da Silva MeirellesL, ChagastellesPC and NardiNB. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 119:2204–2213.
2.
HornAP, BernardiA, Luiz FrozzaR, GrudzinskiPB, HoppeJB, de SouzaLF, ChagastellesP, de Souza WyseAT, BernardEA, et al. (2011). Mesenchymal stem cell-conditioned medium triggers neuroinflammation and reactive species generation in organotypic cultures of rat hippocampus. Stem Cells Dev, 20:1171–1181.
3.
ZhangR, LiuY, YanK, ChenL, ChenXR, LiP, ChenFF and JiangXD. (2013). Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation, 10:106.
4.
da Silva MeirellesL, CaplanAI and NardiNB. (2008). In search of the in vivo identity of mesenchymal stem cells. Stem Cells, 26:2287–2299.
5.
Di NicolaM, Carlo-StellaC, MagniM, MilanesiM, LongoniPD, MatteucciP, Grisanti S and GianniAM. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99:3838–3843.
6.
JinP, ZhaoY, LiuH, ChenJ, RenJ, JinJ, BedognettiD, LiuS, WangE, MarincolaF and StroncekD. (2016). Interferon-gamma and Tumor Necrosis Factor-alpha Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype. Sci Rep, 6:26345.
7.
RaicevicG, RouasR, NajarM, StordeurP, BoufkerHI, BronD, MartiatP, GoldmanM, NevessignskyMT and LagneauxL. (2010). Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol, 71:235–244.
8.
WatermanRS, TomchuckSL, HenkleSL and BetancourtAM. (2010). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One, 5:e10088.
9.
DuijvesteinM, WildenbergME, WellingMM, HenninkS, MolendijkI, van ZuylenVL, BosseT, VosAC, de Jonge-MullerES, et al. (2011). Pretreatment with interferon-gamma enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells, 29:1549–1558.
10.
KimDS, JangIK, LeeMW, KoYJ, LeeDH, LeeJW, SungKW, KooHH and YooKH. (2018). Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma. EBioMedicine, 28:261–273.
11.
RenG, ZhangL, ZhaoX, XuG, ZhangY, RobertsAI, ZhaoRC and ShiY. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell, 2:141–150.
12.
SivanathanKN, GronthosS, Rojas-CanalesD, Thierry B and CoatesPT. (2014). Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation. Stem Cell Rev Rep, 10:351–375.
13.
WangG, CaoK, LiuK, XueY, RobertsAI, LiF, HanY, RabsonAB, WangY and ShiY. (2018). Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells. Cell Death Differ, 25:1209–1223.
14.
De MiguelMP, Fuentes-JulianS, Blazquez-MartinezA, PascualCY, AllerMA, AriasJ and Arnalich-MontielF. (2012). Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med, 12:574–591.
15.
HanY, LiX, ZhangY, HanY, ChangF and DingJ. (2019). Mesenchymal stem cells for regenerative medicine. Cells, 8:886.
16.
LiuJ, YuF, SunY, JiangB, ZhangW, YangJ, XuGT, LiangA and LiuS. (2015). Concise reviews: characteristics and potential applications of human dental tissue-derived mesenchymal stem cells. Stem Cells, 33:627–638.
17.
HuL, LiuY and WangS. (2018). Stem cell-based tooth and periodontal regeneration. Oral Dis, 24:696–705.
18.
ShuaiY, MaY, GuoT, ZhangL, YangR, QiM, LiuW and JinY. (2018). Dental stem cells and tooth regeneration. Adv Exp Med Biol, 1107:41–52.
19.
Hernandez-MonjarazB, Santiago-OsorioE, Monroy-GarciaA, Ledesma-MartinezE and Mendoza-NunezVM. (2018). Mesenchymal Stem Cells of Dental Origin for Inducing Tissue Regeneration in Periodontitis: a mini-review. Int J Mol Sci, 19:944.
HuangGT, YamazaT, SheaLD, DjouadF, KuhnNZ, TuanRS and ShiS. (2010). Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model. Tissue Eng Part A, 16:605–615.
22.
FranchiS, ValsecchiAE, BorsaniE, ProcacciP, FerrariD, ZalfaC, SartoriP, RodellaLF, VescoviA, et al. (2012). Intravenous neural stem cells abolish nociceptive hypersensitivity and trigger nerve regeneration in experimental neuropathy. Pain, 153:850–861.
23.
ForouzanfarF, AminB, GhorbaniA, GhazaviH, GhasemiF, SadriK, MehriS, SadeghniaHR and HosseinzadehH. (2018). New approach for the treatment of neuropathic pain: fibroblast growth factor 1 gene-transfected adipose-derived mesenchymal stem cells. Eur J Pain, 22:295–310.
24.
MertT, KurtAH, AltunI, CelikA, BaranF and GunayI. (2017). Pulsed magnetic field enhances therapeutic efficiency of mesenchymal stem cells in chronic neuropathic pain model. Bioelectromagnetics, 38:255–264.
25.
CooneyDS, WimmersEG, IbrahimZ, GrahammerJ, ChristensenJM, BratGA, WuLW, SarhaneKA, LopezJ, et al. (2016). Mesenchymal stem cells enhance nerve regeneration in a rat sciatic nerve repair and hindlimb transplant model. Sci Rep, 6:31306.
26.
ChiangCY, LiuSA, SheuML, ChenFC, ChenCJ, SuHL and PanHC. (2016). Feasibility of human amniotic fluid derived stem cells in alleviation of neuropathic pain in chronic constrictive injury nerve model. PLoS One, 11:e0159482.
27.
UllahI, ParkJM, KangYH, ByunJH, KimDG, KimJH, KangDH, RhoGJ and ParkBW. (2017). Transplantation of human dental pulp-derived stem cells or differentiated neuronal cells from human dental pulp-derived stem cells identically enhances regeneration of the injured peripheral nerve. Stem Cells Dev, 26:1247–1257.
28.
MartensW, SanenK, GeorgiouM, StruysT, BronckaersA, AmelootM, PhillipsJ and LambrichtsI. (2014). Human dental pulp stem cells can differentiate into Schwann cells and promote and guide neurite outgrowth in an aligned tissue-engineered collagen construct in vitro. FASEB J, 28:1634–1643.
29.
BeigiMH, Ghasemi-MobarakehL, PrabhakaranMP, KarbalaieK, AzadehH, RamakrishnaS, BaharvandH and Nasr-EsfahaniMH. (2014). In vivo integration of poly(epsilon-caprolactone)/gelatin nanofibrous nerve guide seeded with teeth derived stem cells for peripheral nerve regeneration. J Biomed Mater Res A, 102:4554–4567.
KolarMK, ItteVN, KinghamPJ, NovikovLN, WibergM and KelkP. (2017). The neurotrophic effects of different human dental mesenchymal stem cells. Sci Rep, 7:12605.
32.
EsmaeiliA, AlifarjaS, NourbakhshN and TalebiA. (2014). Messenger RNA expression patterns of neurotrophins during transdifferentiation of stem cells from human-exfoliated deciduous teeth into neural-like cells. Avicenna J Med Biotechnol, 6:21–26.
33.
de AlmeidaJF, ChenP, HenryMA and DiogenesA. (2014). Stem cells of the apical papilla regulate trigeminal neurite outgrowth and targeting through a BDNF-dependent mechanism. Tissue Eng Part A, 20:3089–3100.
34.
KumarA, KumarV, RattanV, JhaV and BhattacharyyaS. (2017). Secretome cues modulate the neurogenic potential of bone marrow and dental stem cells. Mol Neurobiol, 54:4672–4682.
35.
SullivanR, DaileyT, DuncanK, AbelN and BorlonganCV. (2016). Peripheral Nerve Injury: stem cell therapy and peripheral nerve transfer. Int J Mol Sci, 17:2101.
36.
LiR, LiuZ, PanY, ChenL, ZhangZ and LuL. (2014). Peripheral nerve injuries treatment: a systematic review. Cell Biochem Biophys, 68:449–454.
37.
KilkennyC, BrowneWJ, CuthillIC, EmersonM and AltmanDG. (2012). Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage, 20:256–260.
38.
McGrathJC and LilleyE. (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol, 172:3189–3193.
39.
Rodriguez-GaztelumendiA, SpahnV, LabuzD, MachelskaH and SteinC. (2018). Analgesic effects of a novel pH-dependent mu-opioid receptor agonist in models of neuropathic and abdominal pain. Pain, 159:2277–2284.
40.
XieJY, QuC, MunroG, PetersenKA and PorrecaF. (2019). Antihyperalgesic effects of Meteorin in the rat chronic constriction injury model: a replication study. Pain, 160:1847–1855.
41.
BernardiL, LuisiSB, FernandesR, DalbertoTP, ValentimL, Bogo ChiesJA, Medeiros FossatiAC and PrankeP. (2011). The isolation of stem cells from human deciduous teeth pulp is related to the physiological process of resorption. J Endod, 37:973–979.
DagninoAPA, da SilvaRBM, ChagastellesPC, PereiraTCB, VenturinGT, GreggioS, Costa da CostaJ, BogoMR and CamposMM. (2019). Nociceptin/orphanin FQ receptor modulates painful and fatigue symptoms in a mouse model of fibromyalgia. Pain, 160:1383–1401.
44.
BraunD, LongmanRS and AlbertML. (2005). A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood, 106:2375–2381.
BustinSA, BenesV, GarsonJA, HellemansJ, HuggettJ, KubistaM, MuellerR, NolanT, PfafflMW, et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem, 55:611–622.
47.
BustinSA, BenesV, GarsonJ, HellemansJ, HuggettJ, KubistaM, MuellerR, NolanT, PfafflMW, et al. (2013). The need for transparency and good practices in the qPCR literature. Nat Methods, 10:1063–1067.
48.
Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res, 29:e45.
49.
GeorgeD, AhrensP and LambertS. (2018). Satellite glial cells represent a population of developmentally arrested Schwann cells. Glia, 66:1496–1506.
50.
SokolCL and LusterAD. (2015). The chemokine system in innate immunity. Cold Spring Harb Perspect Biol, 7:a016303.
51.
HoSY, ChaoCY, HuangHL, ChiuTW, CharoenkwanP and HwangE. (2011). NeurphologyJ: an automatic neuronal morphology quantification method and its application in pharmacological discovery. BMC Bioinformatics, 12:230.
52.
AustinPJ, WuA and Moalem-TaylorG. (2012). Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats. J Vis Exp, 61:3393.
53.
KomulainenA and OlsonME. (1991). Antagonism of ketamine-xylazine anesthesia in rats by administration of yohimbine, tolazoline, or 4-aminopyridine. Am J Vet Res, 52:585–588.
54.
MazeM and TranquilliW. (1991). Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology, 74:581–605.
55.
FarghalyHS, Abd-EllatiefRB, MoftahMZ, MostafaMG, KhedrEM and KotbHI. (2014). The effects of dexmedetomidine alone and in combination with tramadol or amitriptyline in a neuropathic pain model. Pain Physician, 17:187–195.
56.
TegederI, NiederbergerE, SchmidtR, KunzS, GuhringH, RitzelerO, MichaelisM and GeisslingerG. (2004). Specific Inhibition of IkappaB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci, 24:1637–1645.
57.
SotocinalSG, SorgeRE, ZaloumA, TuttleAH, MartinLJ, WieskopfJS, MapplebeckJC, WeiP, ZhanS, et al. (2011). The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol Pain, 7:55.
58.
SilvaRBM, GreggioS, VenturinGT, da CostaJC, GomezMV and CamposMM. (2018). Beneficial effects of the calcium channel blocker CTK 01512-2 in a mouse model of multiple sclerosis. Mol Neurobiol, 55:9307–9327.
59.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD and HorwitzE. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
60.
WadaN, MenicaninD, ShiS, BartoldPM and GronthosS. (2009). Immunomodulatory properties of human periodontal ligament stem cells. J Cell Physiol, 219:667–676.
61.
GuessAJ, DaneaultB, WangR, BradburyH, La PerleKMD, FitchJ, HedrickSL, HamelbergE, CAstbury, et al. (2017). Safety profile of good manufacturing practice manufactured interferon gamma-primed mesenchymal stem/stromal cells for clinical trials. Stem Cells Transl Med, 6:1868–1879.
62.
BiondilloDE, KonicekSA and IwamotoGK. (1994). Interferon-gamma regulation of interleukin 6 in monocytic cells. Am J Physiol, 267,(5 Pt 1)::L564–L568.
63.
KohSH, KimKS, ChoiMR, JungKH, ParkKS, ChaiYG, RohW, HwangSJ, KoHJ, et al. (2008). Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res, 1229:233–248.
64.
DaiLG, HuangGS and HsuSH. (2013). Sciatic nerve regeneration by cocultured Schwann cells and stem cells on microporous nerve conduits. Cell Transplant, 22:2029–2039.
65.
SoriaJM, Sancho-TelloM, EsparzaMA, MirabetV, BaganJV, MonleonM and CardaC. (2011). Biomaterials coated by dental pulp cells as substrate for neural stem cell differentiation. J Biomed Mater Res A, 97:85–92.
66.
KumarA, Kaur H and SinghA. (2018). Neuropathic Pain models caused by damage to central or peripheral nervous system. Pharmacol Rep, 70:206–216.
67.
KimBS, ChunSY, LeeEH, ChungJW, LeeJN, HaYS, ChoiJY, SongPH, KwonTG, et al. (2020). Efficacy of combination therapy with pentosan polysulfate sodium and adipose tissue-derived stem cells for the management of interstitial cystitis in a rat model. Stem Cell Res, 45:101801.
68.
ShalabySM, El-ShalAS, AhmedFE, ShabanSF, WahdanRA, KandelWA and SengerMS. (2017). Combined Wharton's jelly derived mesenchymal stem cells and nerve guidance conduit: a potential promising therapy for peripheral nerve injuries. Int J Biochem Cell Biol, 86:67–76.
69.
KeX, LiQ, XuL, ZhangY, LiD, MaJ and MaoX. (2015). Netrin-1 overexpression in bone marrow mesenchymal stem cells promotes functional recovery in a rat model of peripheral nerve injury. J Biomed Res, 29:380–389.
70.
FrankL, WiegandSJ, SiuciakJA, LindsayRM and RudgeJS. (1997). Effects of BDNF infusion on the regulation of TrkB protein and message in adult rat brain. Exp Neurol, 145:62–70.
71.
GrothR and AanonsenL. (2002). Spinal brain-derived neurotrophic factor (BDNF) produces hyperalgesia in normal mice while antisense directed against either BDNF or trkB, prevent inflammation-induced hyperalgesia. Pain, 100:171–181.
72.
XuQ, ZhangM, LiuJ and LiW. (2013). Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release of GDNF. Ann Clin Lab Sci, 43:154–162.
73.
TawabSA, OmarSMM, ZeidAAA and SabaC. (2018). Role of Adipose Tissue-Derived Stem Cells versus Differentiated Schwann-like cells Transplantation on the Regeneration of Crushed Sciatic Nerve in Rats. A Histological Study. Int J Stem Cell Res Ther, 1:1–10.
74.
JessenKR and MirskyR. (2019). The success and failure of the schwann cell response to nerve injury. Front Cell Neurosci, 13:33.
75.
HuangCW, HuangWC, QiuX, Fernandes Ferreira da SilvaF, WangA, PatelS, NestiLJ, PooMM and LiS. (2017). The differentiation stage of transplanted stem cells modulates nerve regeneration. Sci Rep, 7:17401.
76.
ChenJ, RenS, DuscherD, KangY, LiuY, WangC, YuanM, GuoG, XiongH, et al. (2019). Exosomes from human adipose-derived stem cells promote sciatic nerve regeneration via optimizing Schwann cell function. J Cell Physiol, 234:23097–23110.
77.
Brosius Lutz A and BarresBA. (2014). Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev Cell, 28:7–17.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
